Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 6.35360180 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.72145766 |
3 | negative regulation of cell killing (GO:0031342) | 5.46931626 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.46931626 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.79526881 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78448256 |
7 | regulation of phospholipase A2 activity (GO:0032429) | 4.53762472 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51950345 |
9 | B cell receptor signaling pathway (GO:0050853) | 4.39271955 |
10 | establishment of skin barrier (GO:0061436) | 4.32259816 |
11 | immunoglobulin mediated immune response (GO:0016064) | 4.22441249 |
12 | sphingoid metabolic process (GO:0046519) | 4.09320312 |
13 | positive regulation of B cell differentiation (GO:0045579) | 4.04889677 |
14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04153564 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99455486 |
16 | positive regulation of antigen processing and presentation (GO:0002579) | 3.97776271 |
17 | regulation of water loss via skin (GO:0033561) | 3.95334748 |
18 | glucosamine-containing compound catabolic process (GO:1901072) | 3.90193213 |
19 | response to peptidoglycan (GO:0032494) | 3.88927836 |
20 | keratinization (GO:0031424) | 3.83865563 |
21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.82749702 |
22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.82534855 |
23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.82463825 |
24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.81394806 |
25 | sphingosine metabolic process (GO:0006670) | 3.67343628 |
26 | negative regulation of interleukin-12 production (GO:0032695) | 3.67195669 |
27 | regulation of mast cell degranulation (GO:0043304) | 3.59139124 |
28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.56018260 |
29 | defense response to protozoan (GO:0042832) | 3.56005905 |
30 | T cell migration (GO:0072678) | 3.53192534 |
31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52399274 |
32 | positive regulation of mast cell activation (GO:0033005) | 3.50908302 |
33 | response to muramyl dipeptide (GO:0032495) | 3.40271324 |
34 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.40090575 |
35 | B cell mediated immunity (GO:0019724) | 3.39765483 |
36 | positive thymic T cell selection (GO:0045059) | 3.39709513 |
37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.37340203 |
38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35034620 |
39 | regulation of B cell differentiation (GO:0045577) | 3.34977585 |
40 | type I interferon signaling pathway (GO:0060337) | 3.34905250 |
41 | cellular response to type I interferon (GO:0071357) | 3.34905250 |
42 | response to type I interferon (GO:0034340) | 3.34701336 |
43 | positive regulation of vesicle fusion (GO:0031340) | 3.33943347 |
44 | regulation of antigen processing and presentation (GO:0002577) | 3.33685285 |
45 | response to host immune response (GO:0052572) | 3.32980314 |
46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32980314 |
47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32836617 |
48 | diol metabolic process (GO:0034311) | 3.32162495 |
49 | myeloid cell activation involved in immune response (GO:0002275) | 3.29777608 |
50 | germinal center formation (GO:0002467) | 3.28503124 |
51 | negative thymic T cell selection (GO:0045060) | 3.27168361 |
52 | keratinocyte proliferation (GO:0043616) | 3.26978290 |
53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26626314 |
54 | response to protozoan (GO:0001562) | 3.22607494 |
55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21150042 |
56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20237490 |
57 | cellular extravasation (GO:0045123) | 3.19811116 |
58 | neutrophil activation (GO:0042119) | 3.17205584 |
59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16220553 |
60 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.15417007 |
61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13244999 |
62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.10641503 |
63 | fatty acid elongation (GO:0030497) | 3.09348055 |
64 | detection of molecule of bacterial origin (GO:0032490) | 3.09047197 |
65 | negative T cell selection (GO:0043383) | 3.08819958 |
66 | detection of biotic stimulus (GO:0009595) | 3.07657088 |
67 | hemidesmosome assembly (GO:0031581) | 3.07574342 |
68 | regulation of leukocyte degranulation (GO:0043300) | 3.07265343 |
69 | B cell homeostasis (GO:0001782) | 3.07071309 |
70 | response to host (GO:0075136) | 3.06253508 |
71 | response to host defenses (GO:0052200) | 3.06253508 |
72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06253508 |
73 | negative regulation of innate immune response (GO:0045824) | 3.06063996 |
74 | granulocyte activation (GO:0036230) | 3.03982448 |
75 | leukocyte aggregation (GO:0070486) | 3.02967335 |
76 | keratinocyte differentiation (GO:0030216) | 3.02755994 |
77 | response to interleukin-15 (GO:0070672) | 3.02102717 |
78 | regulation of hypersensitivity (GO:0002883) | 3.01634175 |
79 | regulation of mast cell activation (GO:0033003) | 3.00971674 |
80 | positive regulation of type 2 immune response (GO:0002830) | 3.00099528 |
81 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.97936301 |
82 | positive regulation of B cell mediated immunity (GO:0002714) | 2.97936301 |
83 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.95798262 |
84 | positive regulation of interleukin-10 production (GO:0032733) | 2.93703569 |
85 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90668459 |
86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90668459 |
87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.88268378 |
88 | positive regulation of mast cell degranulation (GO:0043306) | 2.88268378 |
89 | cytidine catabolic process (GO:0006216) | 2.87491695 |
90 | cytidine deamination (GO:0009972) | 2.87491695 |
91 | cytidine metabolic process (GO:0046087) | 2.87491695 |
92 | myeloid dendritic cell activation (GO:0001773) | 2.87253566 |
93 | intermediate filament organization (GO:0045109) | 2.85162711 |
94 | T-helper 1 type immune response (GO:0042088) | 2.83213745 |
95 | myeloid dendritic cell differentiation (GO:0043011) | 2.82370436 |
96 | mast cell activation (GO:0045576) | 2.81656033 |
97 | regulation of tolerance induction (GO:0002643) | 2.81136208 |
98 | multicellular organismal water homeostasis (GO:0050891) | 2.80755558 |
99 | leukocyte degranulation (GO:0043299) | 2.80466052 |
100 | positive regulation of B cell activation (GO:0050871) | 2.80091506 |
101 | tolerance induction (GO:0002507) | 2.80077023 |
102 | neutrophil activation involved in immune response (GO:0002283) | 2.78974740 |
103 | T cell selection (GO:0045058) | 2.78641265 |
104 | positive regulation of isotype switching (GO:0045830) | 2.77643462 |
105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76981551 |
106 | eosinophil chemotaxis (GO:0048245) | 2.75102497 |
107 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.74666786 |
108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74485633 |
109 | detection of bacterium (GO:0016045) | 2.73274362 |
110 | phospholipid efflux (GO:0033700) | 2.73127689 |
111 | water homeostasis (GO:0030104) | 2.67151192 |
112 | regulation of interleukin-8 secretion (GO:2000482) | 2.67130925 |
113 | cellular response to interferon-alpha (GO:0035457) | 2.66258966 |
114 | regulation of chemokine secretion (GO:0090196) | 2.65609412 |
115 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65295888 |
116 | primary alcohol catabolic process (GO:0034310) | 2.64608006 |
117 | eosinophil migration (GO:0072677) | 2.61952320 |
118 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.61677699 |
119 | positive regulation of chemokine secretion (GO:0090197) | 2.60503580 |
120 | detection of other organism (GO:0098543) | 2.59139721 |
121 | regulation of monocyte chemotaxis (GO:0090025) | 2.59012486 |
122 | response to phenylpropanoid (GO:0080184) | 2.56299412 |
123 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.52120037 |
124 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.49197898 |
125 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.48370972 |
126 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.47220585 |
127 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.45096465 |
128 | negative regulation of acute inflammatory response (GO:0002674) | 2.44403563 |
129 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.43892923 |
130 | peptide cross-linking (GO:0018149) | 2.43085204 |
131 | regulation of natural killer cell differentiation (GO:0032823) | 2.42531939 |
132 | regulation of ruffle assembly (GO:1900027) | 2.40767782 |
133 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.40156493 |
134 | cellular copper ion homeostasis (GO:0006878) | 2.37916963 |
135 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.36014166 |
136 | respiratory burst (GO:0045730) | 2.34583451 |
137 | alkaloid metabolic process (GO:0009820) | 2.34583019 |
138 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.33930857 |
139 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.33264467 |
140 | microglial cell activation (GO:0001774) | 2.32846909 |
141 | positive regulation of glomerulus development (GO:0090193) | 2.32172200 |
142 | prostanoid biosynthetic process (GO:0046457) | 2.30568766 |
143 | prostaglandin biosynthetic process (GO:0001516) | 2.30568766 |
144 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.30545980 |
145 | interferon-gamma secretion (GO:0072643) | 2.29690559 |
146 | sympathetic nervous system development (GO:0048485) | 2.28713068 |
147 | prostanoid metabolic process (GO:0006692) | 2.27654907 |
148 | prostaglandin metabolic process (GO:0006693) | 2.27654907 |
149 | phagosome maturation (GO:0090382) | 2.27550024 |
150 | detection of external biotic stimulus (GO:0098581) | 2.24892362 |
151 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.21312861 |
152 | ATP synthesis coupled proton transport (GO:0015986) | 2.21312861 |
153 | lipoxygenase pathway (GO:0019372) | 2.20935518 |
154 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.20123907 |
155 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.20111150 |
156 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.20111150 |
157 | modulation by symbiont of host immune response (GO:0052553) | 2.20111150 |
158 | positive regulation by symbiont of host defense response (GO:0052509) | 2.20111150 |
159 | modulation by symbiont of host defense response (GO:0052031) | 2.20111150 |
160 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.20111150 |
161 | monocyte chemotaxis (GO:0002548) | 2.19121721 |
162 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.18061958 |
163 | membrane budding (GO:0006900) | 2.17866392 |
164 | fibrinolysis (GO:0042730) | 2.17699363 |
165 | regulation of cholesterol esterification (GO:0010872) | 2.16729760 |
166 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.16364157 |
167 | positive regulation of cholesterol efflux (GO:0010875) | 2.15934141 |
168 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.15253408 |
169 | T-helper cell differentiation (GO:0042093) | 2.15253408 |
170 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.13580145 |
171 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.13460819 |
172 | macrophage activation involved in immune response (GO:0002281) | 2.12457628 |
173 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.12183670 |
174 | L-phenylalanine catabolic process (GO:0006559) | 2.12183670 |
175 | negative regulation of lipase activity (GO:0060192) | 2.11544885 |
176 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.11522116 |
177 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.11151291 |
178 | carnitine metabolic process (GO:0009437) | 2.10910363 |
179 | ethanol metabolic process (GO:0006067) | 2.10872977 |
180 | positive regulation of sterol transport (GO:0032373) | 2.10644341 |
181 | positive regulation of cholesterol transport (GO:0032376) | 2.10644341 |
182 | epidermal cell differentiation (GO:0009913) | 2.10609454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.30874916 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.39880563 |
3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38665971 |
4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.05019025 |
5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.02896784 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.88669096 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 2.87552132 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65940308 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64172720 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63116446 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60434198 |
12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.51205120 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49177708 |
14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48387204 |
15 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.47038334 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46184777 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.32980284 |
18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.28871778 |
19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27855663 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24122365 |
21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22584478 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.21291664 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20023841 |
24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.18548707 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.15553183 |
26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14055300 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12936905 |
28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11532020 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06153997 |
30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02205958 |
31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01647971 |
32 | MYB_26560356_Chip-Seq_TH1_Human | 1.89037949 |
33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88425342 |
34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88295397 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84830573 |
36 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.83797098 |
37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.82063266 |
38 | MAF_26560356_Chip-Seq_TH2_Human | 1.81049303 |
39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77575425 |
40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76446893 |
41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75899129 |
42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.75781263 |
43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75353792 |
44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73887325 |
45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73526483 |
46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72729713 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72683666 |
48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71389554 |
49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64383093 |
50 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59767086 |
51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59339570 |
52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58823236 |
53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57557613 |
54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.57356611 |
55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56373851 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55334360 |
57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.55173686 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52023536 |
59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50157340 |
60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49870697 |
61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47958679 |
62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.47180169 |
63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46876722 |
64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46072893 |
65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.45540069 |
66 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43869781 |
67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42563663 |
68 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41030685 |
69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39606330 |
70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39309284 |
71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39279661 |
72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39156147 |
73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36815066 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36149600 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35037754 |
76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35037754 |
77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35004772 |
78 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.33459014 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32046983 |
80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31279731 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30722057 |
82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30548433 |
83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29924693 |
84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28550379 |
85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27932258 |
86 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27790148 |
87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27726649 |
88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24996514 |
89 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.24263458 |
90 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23881967 |
91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23645575 |
92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23116126 |
93 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.21475772 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20630965 |
95 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20124819 |
96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19748769 |
97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18515069 |
98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18508896 |
99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16964612 |
100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16682285 |
101 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.16384421 |
102 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14555793 |
103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14191584 |
104 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14181203 |
105 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13543850 |
106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12076865 |
107 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11581472 |
108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11518100 |
109 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10523225 |
110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09936080 |
111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09619340 |
112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09206439 |
113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09177190 |
114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09121116 |
115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08548023 |
116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08546230 |
117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06253594 |
118 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.04874147 |
119 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04105485 |
120 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02965918 |
121 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01806877 |
122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00761438 |
123 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00092330 |
124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00061542 |
125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99097603 |
126 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99043479 |
127 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99025085 |
128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99011119 |
129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98512019 |
130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98436679 |
131 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97420256 |
132 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96740917 |
133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96628391 |
134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95720382 |
135 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95307650 |
136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95180131 |
137 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95180131 |
138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94808124 |
139 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94554045 |
140 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94446220 |
141 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93986279 |
142 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93650874 |
143 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93587271 |
144 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92999524 |
145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92980376 |
146 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92901214 |
147 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91570741 |
148 | P68_20966046_ChIP-Seq_HELA_Human | 0.90958430 |
149 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89322717 |
150 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.88591794 |
151 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86871034 |
152 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86445840 |
153 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86305392 |
154 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85330667 |
155 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.83385978 |
156 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83082427 |
157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82784746 |
158 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80725289 |
159 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80448022 |
160 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79854906 |
161 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.78791410 |
162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78780410 |
163 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78241223 |
164 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77792499 |
165 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77560231 |
166 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.77449515 |
167 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76614841 |
168 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76170752 |
169 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74851750 |
170 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74512938 |
171 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74349472 |
172 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73292919 |
173 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73051451 |
174 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.72975476 |
175 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.72954108 |
176 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.72246286 |
177 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.71670173 |
178 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71645534 |
179 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71395428 |
180 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.71201930 |
181 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.71201930 |
182 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.70463832 |
183 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.69991298 |
184 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69955698 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 4.73637085 |
2 | MP0002796_impaired_skin_barrier | 4.61609086 |
3 | MP0003303_peritoneal_inflammation | 4.36151303 |
4 | MP0004381_abnormal_hair_follicle | 3.73508393 |
5 | MP0005464_abnormal_platelet_physiology | 3.29335736 |
6 | MP0003941_abnormal_skin_development | 2.88271318 |
7 | MP0005275_abnormal_skin_tensile | 2.57245259 |
8 | MP0002148_abnormal_hypersensitivity_rea | 2.48507877 |
9 | MP0002420_abnormal_adaptive_immunity | 2.48224441 |
10 | MP0001819_abnormal_immune_cell | 2.45539243 |
11 | MP0003763_abnormal_thymus_physiology | 2.41056708 |
12 | MP0005501_abnormal_skin_physiology | 2.36537088 |
13 | MP0001346_abnormal_lacrimal_gland | 2.33411179 |
14 | MP0001835_abnormal_antigen_presentation | 2.27263573 |
15 | MP0003300_gastrointestinal_ulcer | 2.20346643 |
16 | MP0002398_abnormal_bone_marrow | 2.14094014 |
17 | MP0002060_abnormal_skin_morphology | 2.12459670 |
18 | MP0010155_abnormal_intestine_physiology | 2.06470284 |
19 | MP0003195_calcinosis | 2.03823219 |
20 | MP0003436_decreased_susceptibility_to | 2.01747161 |
21 | MP0000716_abnormal_immune_system | 1.97281933 |
22 | MP0001216_abnormal_epidermal_layer | 1.97083876 |
23 | MP0010386_abnormal_urinary_bladder | 1.87785389 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.86441633 |
25 | MP0008260_abnormal_autophagy | 1.85633827 |
26 | MP0003011_delayed_dark_adaptation | 1.81280116 |
27 | MP0000383_abnormal_hair_follicle | 1.80972879 |
28 | MP0003453_abnormal_keratinocyte_physiol | 1.80614457 |
29 | MP0010771_integument_phenotype | 1.80532411 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.79552086 |
31 | MP0002405_respiratory_system_inflammati | 1.78842573 |
32 | MP0004947_skin_inflammation | 1.78485757 |
33 | MP0002009_preneoplasia | 1.76525422 |
34 | MP0002638_abnormal_pupillary_reflex | 1.75579301 |
35 | MP0000689_abnormal_spleen_morphology | 1.70901205 |
36 | MP0003172_abnormal_lysosome_physiology | 1.70328732 |
37 | MP0009278_abnormal_bone_marrow | 1.69532753 |
38 | MP0009379_abnormal_foot_pigmentation | 1.68457680 |
39 | MP0002277_abnormal_respiratory_mucosa | 1.65675197 |
40 | MP0002429_abnormal_blood_cell | 1.63761503 |
41 | MP0005451_abnormal_body_composition | 1.63632121 |
42 | MP0010234_abnormal_vibrissa_follicle | 1.61784263 |
43 | MP0002722_abnormal_immune_system | 1.61629637 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.54650372 |
45 | MP0000579_abnormal_nail_morphology | 1.54234434 |
46 | MP0002098_abnormal_vibrissa_morphology | 1.54042002 |
47 | MP0001790_abnormal_immune_system | 1.53307109 |
48 | MP0005387_immune_system_phenotype | 1.53307109 |
49 | MP0004782_abnormal_surfactant_physiolog | 1.53301501 |
50 | MP0002090_abnormal_vision | 1.53296917 |
51 | MP0002876_abnormal_thyroid_physiology | 1.52484465 |
52 | MP0001545_abnormal_hematopoietic_system | 1.47484703 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.47484703 |
54 | MP0001851_eye_inflammation | 1.46437033 |
55 | MP0003191_abnormal_cellular_cholesterol | 1.41433690 |
56 | MP0000685_abnormal_immune_system | 1.39985709 |
57 | MP0003724_increased_susceptibility_to | 1.36950932 |
58 | MP0000703_abnormal_thymus_morphology | 1.36613280 |
59 | MP0002163_abnormal_gland_morphology | 1.35904930 |
60 | MP0003828_pulmonary_edema | 1.35296355 |
61 | MP0009785_altered_susceptibility_to | 1.34503311 |
62 | MP0000858_altered_metastatic_potential | 1.34237783 |
63 | MP0000647_abnormal_sebaceous_gland | 1.33118526 |
64 | MP0005085_abnormal_gallbladder_physiolo | 1.32507687 |
65 | MP0010678_abnormal_skin_adnexa | 1.32463092 |
66 | MP0005000_abnormal_immune_tolerance | 1.31649890 |
67 | MP0006082_CNS_inflammation | 1.31183803 |
68 | MP0004019_abnormal_vitamin_homeostasis | 1.30441990 |
69 | MP0000538_abnormal_urinary_bladder | 1.29375537 |
70 | MP0000343_altered_response_to | 1.28722711 |
71 | MP0003183_abnormal_peptide_metabolism | 1.26524397 |
72 | MP0005058_abnormal_lysosome_morphology | 1.24765211 |
73 | MP0002132_abnormal_respiratory_system | 1.23857294 |
74 | MP0002139_abnormal_hepatobiliary_system | 1.23566430 |
75 | MP0005025_abnormal_response_to | 1.23438435 |
76 | MP0003075_altered_response_to | 1.20493275 |
77 | MP0005379_endocrine/exocrine_gland_phen | 1.20358607 |
78 | MP0002998_abnormal_bone_remodeling | 1.18715665 |
79 | MP0000427_abnormal_hair_cycle | 1.16461269 |
80 | MP0002419_abnormal_innate_immunity | 1.15726681 |
81 | MP0003866_abnormal_defecation | 1.15393385 |
82 | MP0005310_abnormal_salivary_gland | 1.15376156 |
83 | MP0009840_abnormal_foam_cell | 1.12369448 |
84 | MP0005360_urolithiasis | 1.11931062 |
85 | MP0003638_abnormal_response/metabolism_ | 1.10512735 |
86 | MP0005083_abnormal_biliary_tract | 1.10455821 |
87 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08506260 |
88 | MP0001191_abnormal_skin_condition | 1.07501436 |
89 | MP0002332_abnormal_exercise_endurance | 1.06708874 |
90 | MP0005535_abnormal_body_temperature | 1.04311377 |
91 | MP0000015_abnormal_ear_pigmentation | 1.03332385 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 1.01357310 |
93 | MP0001800_abnormal_humoral_immune | 0.98396125 |
94 | MP0005075_abnormal_melanosome_morpholog | 0.98020551 |
95 | MP0004808_abnormal_hematopoietic_stem | 0.97072250 |
96 | MP0002837_dystrophic_cardiac_calcinosis | 0.96916109 |
97 | MP0009763_increased_sensitivity_to | 0.96065823 |
98 | MP0002166_altered_tumor_susceptibility | 0.96018100 |
99 | MP0002822_catalepsy | 0.95367467 |
100 | MP0002396_abnormal_hematopoietic_system | 0.95206936 |
101 | MP0000377_abnormal_hair_follicle | 0.93978346 |
102 | MP0000604_amyloidosis | 0.93674951 |
103 | MP0005365_abnormal_bile_salt | 0.92886783 |
104 | MP0005166_decreased_susceptibility_to | 0.91474000 |
105 | MP0001984_abnormal_olfaction | 0.91331436 |
106 | MP0001663_abnormal_digestive_system | 0.89743811 |
107 | MP0009764_decreased_sensitivity_to | 0.89639764 |
108 | MP0001533_abnormal_skeleton_physiology | 0.89486798 |
109 | MP0001845_abnormal_inflammatory_respons | 0.89331306 |
110 | MP0001853_heart_inflammation | 0.86264608 |
111 | MP0000013_abnormal_adipose_tissue | 0.86243644 |
112 | MP0008004_abnormal_stomach_pH | 0.85633580 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.85320111 |
114 | MP0003566_abnormal_cell_adhesion | 0.85199522 |
115 | MP0005671_abnormal_response_to | 0.85083100 |
116 | MP0000467_abnormal_esophagus_morphology | 0.84609746 |
117 | MP0005167_abnormal_blood-brain_barrier | 0.84333357 |
118 | MP0002006_tumorigenesis | 0.84193924 |
119 | MP0000249_abnormal_blood_vessel | 0.82429679 |
120 | MP0000490_abnormal_crypts_of | 0.82407235 |
121 | MP0008469_abnormal_protein_level | 0.82369539 |
122 | MP0005332_abnormal_amino_acid | 0.82367167 |
123 | MP0008874_decreased_physiological_sensi | 0.82286913 |
124 | MP0009931_abnormal_skin_appearance | 0.82176786 |
125 | MP0002723_abnormal_immune_serum | 0.82100629 |
126 | MP0010329_abnormal_lipoprotein_level | 0.80257615 |
127 | MP0002452_abnormal_antigen_presenting | 0.79437603 |
128 | MP0005666_abnormal_adipose_tissue | 0.79379015 |
129 | MP0002735_abnormal_chemical_nociception | 0.79246171 |
130 | MP0000367_abnormal_coat/_hair | 0.79056338 |
131 | MP0003136_yellow_coat_color | 0.77765564 |
132 | MP0001243_abnormal_dermal_layer | 0.77458382 |
133 | MP0004185_abnormal_adipocyte_glucose | 0.77413457 |
134 | MP0001666_abnormal_nutrient_absorption | 0.75409039 |
135 | MP0001881_abnormal_mammary_gland | 0.75028821 |
136 | MP0004130_abnormal_muscle_cell | 0.74634266 |
137 | MP0002118_abnormal_lipid_homeostasis | 0.72853598 |
138 | MP0004270_analgesia | 0.72137166 |
139 | MP0006276_abnormal_autonomic_nervous | 0.71599140 |
140 | MP0004510_myositis | 0.69821692 |
141 | MP0003448_altered_tumor_morphology | 0.69483290 |
142 | MP0005551_abnormal_eye_electrophysiolog | 0.69140655 |
143 | MP0002933_joint_inflammation | 0.68858767 |
144 | MP0003690_abnormal_glial_cell | 0.68008127 |
145 | MP0002971_abnormal_brown_adipose | 0.67630601 |
146 | MP0009643_abnormal_urine_homeostasis | 0.67618835 |
147 | MP0004883_abnormal_blood_vessel | 0.66357464 |
148 | MP0002019_abnormal_tumor_incidence | 0.64908258 |
149 | MP0003045_fibrosis | 0.63768223 |
150 | MP0005174_abnormal_tail_pigmentation | 0.63245079 |
151 | MP0005390_skeleton_phenotype | 0.59899880 |
152 | MP0003091_abnormal_cell_migration | 0.58718530 |
153 | MP0009115_abnormal_fat_cell | 0.57464632 |
154 | MP0000609_abnormal_liver_physiology | 0.50310940 |
155 | MP0001873_stomach_inflammation | 0.50209446 |
156 | MP0000920_abnormal_myelination | 0.48686701 |
157 | MP0004036_abnormal_muscle_relaxation | 0.47481691 |
158 | MP0005381_digestive/alimentary_phenotyp | 0.46767553 |
159 | MP0002877_abnormal_melanocyte_morpholog | 0.45642468 |
160 | MP0005164_abnormal_response_to | 0.45402985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Parakeratosis (HP:0001036) | 4.62316059 |
2 | Agammaglobulinemia (HP:0004432) | 4.52146632 |
3 | Prolonged bleeding time (HP:0003010) | 4.27874157 |
4 | Meningitis (HP:0001287) | 4.15939197 |
5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.95857736 |
6 | Gastrointestinal stroma tumor (HP:0100723) | 3.87806180 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 3.87258787 |
8 | Purpura (HP:0000979) | 3.84089485 |
9 | Plantar hyperkeratosis (HP:0007556) | 3.77880426 |
10 | Colitis (HP:0002583) | 3.70145505 |
11 | Petechiae (HP:0000967) | 3.70070779 |
12 | Palmoplantar hyperkeratosis (HP:0000972) | 3.69578209 |
13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.68327598 |
14 | Vasculitis (HP:0002633) | 3.68001487 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66521762 |
16 | Obstructive lung disease (HP:0006536) | 3.66521762 |
17 | Panhypogammaglobulinemia (HP:0003139) | 3.63462527 |
18 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.62113511 |
19 | Spontaneous hematomas (HP:0007420) | 3.60846404 |
20 | Recurrent fungal infections (HP:0002841) | 3.60344760 |
21 | Cellulitis (HP:0100658) | 3.56307802 |
22 | Epistaxis (HP:0000421) | 3.51591226 |
23 | Systemic lupus erythematosus (HP:0002725) | 3.49171568 |
24 | Recurrent viral infections (HP:0004429) | 3.47956562 |
25 | Inflammation of the large intestine (HP:0002037) | 3.44416076 |
26 | Encephalitis (HP:0002383) | 3.40480947 |
27 | Hypotrichosis (HP:0001006) | 3.39194354 |
28 | Gastrointestinal inflammation (HP:0004386) | 3.38429328 |
29 | Recurrent sinusitis (HP:0011108) | 3.36750685 |
30 | Gingival bleeding (HP:0000225) | 3.31514709 |
31 | Abnormal hemoglobin (HP:0011902) | 3.31318661 |
32 | Recurrent skin infections (HP:0001581) | 3.31177334 |
33 | Conjunctival hamartoma (HP:0100780) | 3.29525007 |
34 | Palmar hyperkeratosis (HP:0010765) | 3.24451864 |
35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.17908395 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.17908395 |
37 | Thick nail (HP:0001805) | 3.14988748 |
38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13185682 |
39 | Eczematoid dermatitis (HP:0000976) | 3.12048021 |
40 | Stomatitis (HP:0010280) | 3.11856042 |
41 | Right ventricular cardiomyopathy (HP:0011663) | 3.05871251 |
42 | Gastrointestinal infarctions (HP:0005244) | 3.05753186 |
43 | Increased IgM level (HP:0003496) | 2.99816015 |
44 | Lip pit (HP:0100267) | 2.97505289 |
45 | Vacuolated lymphocytes (HP:0001922) | 2.94940342 |
46 | Axonal loss (HP:0003447) | 2.93971391 |
47 | Hyporeflexia of lower limbs (HP:0002600) | 2.91054508 |
48 | Increased IgE level (HP:0003212) | 2.90120723 |
49 | Erythema (HP:0010783) | 2.89794623 |
50 | Recurrent bronchitis (HP:0002837) | 2.87521789 |
51 | Abnormality of the axillary hair (HP:0100134) | 2.87280319 |
52 | Abnormality of secondary sexual hair (HP:0009888) | 2.87280319 |
53 | Recurrent bacterial skin infections (HP:0005406) | 2.85571459 |
54 | Xanthomatosis (HP:0000991) | 2.77137593 |
55 | Pulmonary infiltrates (HP:0002113) | 2.74818860 |
56 | Recurrent abscess formation (HP:0002722) | 2.74233300 |
57 | Lymphopenia (HP:0001888) | 2.71029972 |
58 | Woolly hair (HP:0002224) | 2.70528218 |
59 | Keratoconjunctivitis sicca (HP:0001097) | 2.68062705 |
60 | Osteomyelitis (HP:0002754) | 2.65886298 |
61 | Fragile nails (HP:0001808) | 2.65823715 |
62 | Gingivitis (HP:0000230) | 2.65238291 |
63 | Chest pain (HP:0100749) | 2.59400021 |
64 | T lymphocytopenia (HP:0005403) | 2.54920026 |
65 | Abnormal platelet volume (HP:0011876) | 2.54784463 |
66 | Menorrhagia (HP:0000132) | 2.54290311 |
67 | Abnormality of T cells (HP:0002843) | 2.53548872 |
68 | Erythroderma (HP:0001019) | 2.53334655 |
69 | Gangrene (HP:0100758) | 2.52667485 |
70 | Exercise-induced myalgia (HP:0003738) | 2.52174057 |
71 | Hypothermia (HP:0002045) | 2.51876360 |
72 | Natal tooth (HP:0000695) | 2.51831102 |
73 | Abnormality of nail color (HP:0100643) | 2.51177893 |
74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51056778 |
75 | Arterial thrombosis (HP:0004420) | 2.50982167 |
76 | Epidermoid cyst (HP:0200040) | 2.50977790 |
77 | Complement deficiency (HP:0004431) | 2.50497022 |
78 | Onycholysis (HP:0001806) | 2.49957207 |
79 | IgM deficiency (HP:0002850) | 2.49777805 |
80 | Recurrent pneumonia (HP:0006532) | 2.48848968 |
81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48663343 |
82 | Dysostosis multiplex (HP:0000943) | 2.45432111 |
83 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44922661 |
84 | Glomerulonephritis (HP:0000099) | 2.44501232 |
85 | Abnormality of complement system (HP:0005339) | 2.41460985 |
86 | Abnormality of T cell number (HP:0011839) | 2.41413739 |
87 | Restrictive lung disease (HP:0002091) | 2.37080135 |
88 | Pulmonary embolism (HP:0002204) | 2.35856468 |
89 | Emphysema (HP:0002097) | 2.35377652 |
90 | Abnormality of T cell physiology (HP:0011840) | 2.33235075 |
91 | Keratoconjunctivitis (HP:0001096) | 2.32626608 |
92 | Popliteal pterygium (HP:0009756) | 2.32068007 |
93 | Anhidrosis (HP:0000970) | 2.28855238 |
94 | IgA deficiency (HP:0002720) | 2.28516529 |
95 | Chronic otitis media (HP:0000389) | 2.26733294 |
96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26369977 |
97 | Exercise-induced muscle cramps (HP:0003710) | 2.26200222 |
98 | Corneal erosion (HP:0200020) | 2.25892951 |
99 | Hemoptysis (HP:0002105) | 2.23796982 |
100 | Granulocytopenia (HP:0001913) | 2.21758514 |
101 | Papilloma (HP:0012740) | 2.21393273 |
102 | Verrucae (HP:0200043) | 2.21393273 |
103 | IgG deficiency (HP:0004315) | 2.21370928 |
104 | Distal lower limb muscle weakness (HP:0009053) | 2.20969902 |
105 | Acute necrotizing encephalopathy (HP:0006965) | 2.20104340 |
106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19985197 |
107 | Leukocytosis (HP:0001974) | 2.19457399 |
108 | Loss of speech (HP:0002371) | 2.19441328 |
109 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16685583 |
110 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16685583 |
111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16685583 |
112 | Hyperlipoproteinemia (HP:0010980) | 2.15659422 |
113 | Sepsis (HP:0100806) | 2.14999086 |
114 | Abnormal pupillary function (HP:0007686) | 2.14459757 |
115 | Amyloidosis (HP:0011034) | 2.12782531 |
116 | Pustule (HP:0200039) | 2.11936157 |
117 | Increased mean platelet volume (HP:0011877) | 2.10923794 |
118 | Autoimmune hemolytic anemia (HP:0001890) | 2.10696935 |
119 | Calf muscle hypertrophy (HP:0008981) | 2.08055840 |
120 | Fatigue (HP:0012378) | 2.06725958 |
121 | Myocardial infarction (HP:0001658) | 2.06248125 |
122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.05133262 |
123 | Nail dystrophy (HP:0008404) | 2.04319587 |
124 | Viral hepatitis (HP:0006562) | 2.03671679 |
125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03389443 |
126 | Increased cerebral lipofuscin (HP:0011813) | 2.03375751 |
127 | Skin rash (HP:0000988) | 2.03030291 |
128 | Joint swelling (HP:0001386) | 2.03003506 |
129 | Hypohidrosis (HP:0000966) | 2.01456982 |
130 | Prolonged partial thromboplastin time (HP:0003645) | 2.00679479 |
131 | Chronic diarrhea (HP:0002028) | 1.99297955 |
132 | Abnormal platelet function (HP:0011869) | 1.98685834 |
133 | Impaired platelet aggregation (HP:0003540) | 1.98685834 |
134 | Thrombocytosis (HP:0001894) | 1.97833835 |
135 | Hypophosphatemic rickets (HP:0004912) | 1.97713695 |
136 | Hepatosplenomegaly (HP:0001433) | 1.97710794 |
137 | Arthralgia (HP:0002829) | 1.95700080 |
138 | Renal Fanconi syndrome (HP:0001994) | 1.95343294 |
139 | Cerebral hemorrhage (HP:0001342) | 1.95339310 |
140 | Abnormality of the pleura (HP:0002103) | 1.94912813 |
141 | Vascular calcification (HP:0004934) | 1.94264406 |
142 | Ketoacidosis (HP:0001993) | 1.93903780 |
143 | Premature loss of primary teeth (HP:0006323) | 1.93627660 |
144 | Autoimmune thrombocytopenia (HP:0001973) | 1.93169511 |
145 | Acute encephalopathy (HP:0006846) | 1.92728524 |
146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92475456 |
147 | Progressive macrocephaly (HP:0004481) | 1.92281231 |
148 | Palmoplantar keratoderma (HP:0000982) | 1.91553395 |
149 | Hypokinesia (HP:0002375) | 1.90092939 |
150 | Ulnar claw (HP:0001178) | 1.89925867 |
151 | Advanced eruption of teeth (HP:0006288) | 1.87123145 |
152 | Joint hemorrhage (HP:0005261) | 1.87072607 |
153 | Abnormality of renal resorption (HP:0011038) | 1.86927634 |
154 | Pruritus (HP:0000989) | 1.86802413 |
155 | Nephritis (HP:0000123) | 1.86601339 |
156 | Milia (HP:0001056) | 1.86324444 |
157 | Type I diabetes mellitus (HP:0100651) | 1.85469788 |
158 | Orchitis (HP:0100796) | 1.85063223 |
159 | Hypoalphalipoproteinemia (HP:0003233) | 1.84628432 |
160 | Abnormality of macrophages (HP:0004311) | 1.84252382 |
161 | Acanthosis nigricans (HP:0000956) | 1.83818200 |
162 | Urticaria (HP:0001025) | 1.81284779 |
163 | Retrobulbar optic neuritis (HP:0100654) | 1.80608365 |
164 | Optic neuritis (HP:0100653) | 1.80608365 |
165 | Ventricular tachycardia (HP:0004756) | 1.79857475 |
166 | Myoglobinuria (HP:0002913) | 1.79330390 |
167 | Cerebral edema (HP:0002181) | 1.78602226 |
168 | Alopecia of scalp (HP:0002293) | 1.78492547 |
169 | Progressive visual loss (HP:0000529) | 1.77307518 |
170 | Areflexia of lower limbs (HP:0002522) | 1.76716489 |
171 | Hypergammaglobulinemia (HP:0010702) | 1.73849620 |
172 | Muscle fiber inclusion bodies (HP:0100299) | 1.72315676 |
173 | Abnormal blistering of the skin (HP:0008066) | 1.71653928 |
174 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70358532 |
175 | Muscle stiffness (HP:0003552) | 1.70072664 |
176 | Myositis (HP:0100614) | 1.70043225 |
177 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.69561133 |
178 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69067681 |
179 | Cardiovascular calcification (HP:0011915) | 1.66967065 |
180 | Neuroendocrine neoplasm (HP:0100634) | 1.66956473 |
181 | Abnormality of proline metabolism (HP:0010907) | 1.62436003 |
182 | Hydroxyprolinuria (HP:0003080) | 1.62436003 |
183 | Paralysis (HP:0003470) | 1.61892883 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 4.31189683 |
2 | MAP4K1 | 3.90051301 |
3 | MAP3K14 | 3.55301757 |
4 | PRPF4B | 3.12055894 |
5 | MAP3K13 | 3.05294646 |
6 | TYK2 | 2.72103648 |
7 | GRK7 | 2.62724926 |
8 | MST1R | 2.55054771 |
9 | PIK3CG | 2.32397486 |
10 | MAPKAPK3 | 2.31402339 |
11 | MAP2K3 | 2.21707885 |
12 | FES | 2.17885514 |
13 | BLK | 2.10224564 |
14 | MAP3K12 | 2.08957693 |
15 | BTK | 2.02402062 |
16 | MAP3K3 | 2.01558482 |
17 | BMPR2 | 2.00973221 |
18 | TRPM7 | 1.99129739 |
19 | ERBB3 | 1.97769625 |
20 | CDK19 | 1.96385367 |
21 | CSF1R | 1.92206637 |
22 | MAP3K2 | 1.91134979 |
23 | MAPK15 | 1.86883091 |
24 | BMPR1B | 1.86205548 |
25 | BCR | 1.80801614 |
26 | STK24 | 1.76584825 |
27 | TAOK3 | 1.66715221 |
28 | OBSCN | 1.66164867 |
29 | PIM2 | 1.64115267 |
30 | NME2 | 1.62992146 |
31 | GRK5 | 1.56786901 |
32 | KIT | 1.55812889 |
33 | PBK | 1.54341092 |
34 | RIPK4 | 1.50931863 |
35 | FER | 1.47392728 |
36 | TXK | 1.45654870 |
37 | TBK1 | 1.44595966 |
38 | MATK | 1.43801311 |
39 | GRK6 | 1.33647408 |
40 | EPHA3 | 1.32963975 |
41 | LYN | 1.31759591 |
42 | WNK4 | 1.21084250 |
43 | FGFR4 | 1.19966906 |
44 | TAOK2 | 1.18069284 |
45 | KSR2 | 1.17334469 |
46 | MAPKAPK5 | 1.17188679 |
47 | NEK9 | 1.15993776 |
48 | GRK1 | 1.14479300 |
49 | INSRR | 1.14333848 |
50 | IKBKB | 1.06759457 |
51 | NTRK1 | 1.05882889 |
52 | LCK | 1.05218579 |
53 | TEC | 1.03614366 |
54 | DYRK1B | 1.03007609 |
55 | IKBKE | 1.01353866 |
56 | ADRBK1 | 1.00937071 |
57 | ERN1 | 0.97358542 |
58 | ADRBK2 | 0.95567438 |
59 | PDK1 | 0.94851459 |
60 | JAK1 | 0.94448064 |
61 | TRIB3 | 0.93605731 |
62 | BMX | 0.90989259 |
63 | TESK1 | 0.90161875 |
64 | MARK3 | 0.88485060 |
65 | FRK | 0.86173498 |
66 | PDPK1 | 0.86061313 |
67 | CDC42BPA | 0.85820814 |
68 | PRKCE | 0.84814044 |
69 | MET | 0.83757042 |
70 | FGR | 0.83510082 |
71 | CASK | 0.81606858 |
72 | IRAK4 | 0.81522947 |
73 | MARK2 | 0.81491172 |
74 | SIK2 | 0.79573189 |
75 | LRRK2 | 0.78761558 |
76 | TAOK1 | 0.78509057 |
77 | MAP2K4 | 0.78478339 |
78 | EPHB1 | 0.78230228 |
79 | SYK | 0.78058094 |
80 | SMG1 | 0.76506859 |
81 | MAPK12 | 0.76222882 |
82 | JAK2 | 0.75174475 |
83 | JAK3 | 0.75147505 |
84 | PKN1 | 0.72831243 |
85 | TNK2 | 0.72475081 |
86 | BCKDK | 0.72248075 |
87 | MAP2K1 | 0.70324199 |
88 | TTN | 0.69947726 |
89 | YES1 | 0.68827812 |
90 | PIM1 | 0.67897050 |
91 | LIMK1 | 0.67519447 |
92 | MAPK7 | 0.66952291 |
93 | ARAF | 0.66436004 |
94 | MAP3K7 | 0.66292812 |
95 | MAPKAPK2 | 0.65292002 |
96 | MAP3K1 | 0.63444365 |
97 | PTK6 | 0.62835525 |
98 | CDK4 | 0.61858002 |
99 | IRAK3 | 0.61855998 |
100 | MAPK11 | 0.61432918 |
101 | STK39 | 0.59679324 |
102 | RET | 0.58712989 |
103 | PTK2B | 0.57307492 |
104 | MAP3K5 | 0.57203147 |
105 | MAP3K10 | 0.56524312 |
106 | FYN | 0.56324115 |
107 | RAF1 | 0.56237585 |
108 | FGFR3 | 0.55506723 |
109 | MOS | 0.54408060 |
110 | RIPK1 | 0.53221234 |
111 | IRAK1 | 0.53021253 |
112 | MAP3K6 | 0.52028992 |
113 | HCK | 0.51223152 |
114 | EPHB2 | 0.50177868 |
115 | TESK2 | 0.50089315 |
116 | PRKCD | 0.49897117 |
117 | ITK | 0.49779861 |
118 | MAP3K11 | 0.49559034 |
119 | EIF2AK2 | 0.48328567 |
120 | CHUK | 0.48018280 |
121 | CDK12 | 0.47957080 |
122 | PHKG1 | 0.47260092 |
123 | PHKG2 | 0.47260092 |
124 | MAP2K6 | 0.45059557 |
125 | HIPK2 | 0.44913680 |
126 | IGF1R | 0.44304411 |
127 | PLK2 | 0.44110786 |
128 | ERBB4 | 0.43874292 |
129 | MINK1 | 0.42326127 |
130 | NTRK2 | 0.41902714 |
131 | PDK2 | 0.41634878 |
132 | PRKD2 | 0.41621488 |
133 | PRKD1 | 0.41337099 |
134 | MAPK4 | 0.40693204 |
135 | MAP3K9 | 0.40454340 |
136 | PDK4 | 0.40287356 |
137 | PDK3 | 0.40287356 |
138 | STK38L | 0.39764761 |
139 | SGK3 | 0.38195494 |
140 | BRAF | 0.37342625 |
141 | MYLK | 0.37230926 |
142 | TGFBR2 | 0.37086526 |
143 | RPS6KL1 | 0.37039118 |
144 | RPS6KC1 | 0.37039118 |
145 | EGFR | 0.37001609 |
146 | ACVR1B | 0.36813143 |
147 | PRKCQ | 0.36220519 |
148 | CAMKK1 | 0.35717466 |
149 | PRKAA2 | 0.35504003 |
150 | EEF2K | 0.35304644 |
151 | RPS6KA2 | 0.35073563 |
152 | ZAP70 | 0.34980654 |
153 | SIK3 | 0.34758349 |
154 | MAP2K2 | 0.33645296 |
155 | STK10 | 0.33565013 |
156 | IRAK2 | 0.31971304 |
157 | CSK | 0.31617964 |
158 | SGK2 | 0.31432164 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.89987352 |
2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.88572793 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.66008599 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56754956 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.48692334 |
6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.38573404 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34294769 |
8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.08680613 |
9 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.07262550 |
10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05612415 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02023497 |
12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.88038540 |
13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.87300796 |
14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82256653 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76845967 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73148951 |
17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69801546 |
18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.66156248 |
19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65752331 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65582525 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.60312284 |
22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59516594 |
23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.55769528 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50273834 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.49870138 |
26 | Measles_Homo sapiens_hsa05162 | 1.49298488 |
27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46746424 |
28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46633934 |
29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42718457 |
30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42276406 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40378693 |
32 | Allograft rejection_Homo sapiens_hsa05330 | 1.40185976 |
33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39811746 |
34 | Platelet activation_Homo sapiens_hsa04611 | 1.38024580 |
35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37601496 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35968007 |
37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33693200 |
38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30068812 |
39 | Phototransduction_Homo sapiens_hsa04744 | 1.22579198 |
40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21016886 |
41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19963563 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.19388633 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18438496 |
44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17618940 |
45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14891046 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13916524 |
47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13828869 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12268791 |
49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11875674 |
50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11103165 |
51 | Ribosome_Homo sapiens_hsa03010 | 1.08237759 |
52 | Lysosome_Homo sapiens_hsa04142 | 1.07389590 |
53 | Peroxisome_Homo sapiens_hsa04146 | 1.06688559 |
54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04586148 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03719240 |
56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03511957 |
57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02985643 |
58 | Protein export_Homo sapiens_hsa03060 | 1.02603946 |
59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00230400 |
60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99772307 |
61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99312486 |
62 | Hepatitis B_Homo sapiens_hsa05161 | 0.98651333 |
63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97689941 |
64 | Apoptosis_Homo sapiens_hsa04210 | 0.97240510 |
65 | Pertussis_Homo sapiens_hsa05133 | 0.95597833 |
66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93756485 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93570501 |
68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90237547 |
69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88171182 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.87109151 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87094629 |
72 | Shigellosis_Homo sapiens_hsa05131 | 0.86306194 |
73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85856186 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85816128 |
75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83646832 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82894148 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82508062 |
78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80620057 |
79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80332370 |
80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77026564 |
81 | Renin secretion_Homo sapiens_hsa04924 | 0.76580695 |
82 | Asthma_Homo sapiens_hsa05310 | 0.76392884 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76335841 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75537469 |
85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75261325 |
86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74718752 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73471115 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73390656 |
89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73074825 |
90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72812259 |
91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72550963 |
92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72287583 |
93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71326523 |
94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70573528 |
95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69675721 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67195487 |
97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66573115 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65998982 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63419672 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63352691 |
101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62669081 |
102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62416466 |
103 | Malaria_Homo sapiens_hsa05144 | 0.62384117 |
104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62015423 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61263664 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.60893113 |
107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59429653 |
108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59384762 |
109 | Legionellosis_Homo sapiens_hsa05134 | 0.59244632 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58793134 |
111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56962289 |
112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56805406 |
113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56185633 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55529442 |
115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54778806 |
116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53889528 |
117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53364586 |
118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52902980 |
119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52850336 |
120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52661171 |
121 | Tuberculosis_Homo sapiens_hsa05152 | 0.52596019 |
122 | Proteasome_Homo sapiens_hsa03050 | 0.52405116 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51653420 |
124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51322667 |
125 | Mineral absorption_Homo sapiens_hsa04978 | 0.50102535 |
126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49899578 |
127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49059051 |
128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48834889 |
129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47490525 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47251640 |
131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46127635 |
132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45968096 |
133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44244169 |
134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44010921 |
135 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42563948 |
136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42286876 |
137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42175249 |
138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41990982 |
139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41274279 |
140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40894530 |
141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40720582 |
142 | Bile secretion_Homo sapiens_hsa04976 | 0.40236051 |
143 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39885540 |
144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39793790 |
145 | Insulin resistance_Homo sapiens_hsa04931 | 0.38450924 |
146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38063001 |
147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37810462 |
148 | ABC transporters_Homo sapiens_hsa02010 | 0.37517586 |
149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37463691 |
150 | Amoebiasis_Homo sapiens_hsa05146 | 0.36726108 |
151 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36588378 |
152 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36346004 |
153 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36318180 |
154 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35053149 |
155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33433115 |
156 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33335141 |
157 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31893202 |
158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31311629 |
159 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30926984 |
160 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30895574 |
161 | Salmonella infection_Homo sapiens_hsa05132 | 0.30043764 |
162 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29940659 |
163 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29600978 |
164 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27740779 |
165 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27500200 |